and yet the 6 products that TruPharma are targeting have yearly sales of US$440 million. And Amring, one product has US$400 million in sales. Testosterone has sales over US$100 million.Harris targeting a small market only some US$22 million. So we’re targeting some US$962 million in current sales. Would love to know what % ACR thinks they can capture with these 8 products. Is 3-4 % too ambitious? jet
ACR Price at posting:
18.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
